Faculty Affiliation

Amir Krivoy, MD*
National Psychosis Service, South London, and Maudsley NHS Foundation Trust, London, United Kingdom; Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom; and Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Israel

Dan Joyce, MBBS, MRCPsych, PhD
Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

Derek Tracy, MBBS, MSc, FRCPsych
Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom, and Oxleas NHS Foundation Trust, Green Parks House, Orpington, Kent, London, United Kingdom

Fiona Gaughran, MD, FRCPsych, FRCPI, FRCP
National Psychosis Service, South London, and Maudsley NHS Foundation Trust, London, United Kingdom, and Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

James MacCabe, MBBS, FRCPsych, PhD
National Psychosis Service, South London, and Maudsley NHS Foundation Trust, London, United Kingdom, and Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

John Lally, MBBS, MSc, MRCPsych
Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom; Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland; and Department of Psychiatry, School of Medicine and Medical Sciences, University College Dublin, St Vincent’s University Hospital, Dublin, Ireland

Eromona Whiskey, BPharm, MCMHP, MRPharmS
National Psychosis Service, South London, and Maudsley NHS Foundation Trust, London, United Kingdom, and Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

S. Neil Sarkar, MBBS, MRCPsych
Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom, and Central and North West London NHS Foundation Trust, London, United Kingdom

Sukhwinder S. Shergill, MBBS, FRCPsych, PhD
National Psychosis Service, South London, and Maudsley NHS Foundation Trust, London, United Kingdom, and Department of Psychosis Studies, the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom

*Corresponding author: Amir Krivoy, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, PO63, De Crespigny Park, London SE5 8AF, UK (Amir.krivoy@kcl.ac.uk).

Financial Disclosure

All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Marlene P. Freeman, MD, Editor in Chief of The Journal of Clinical Psychiatry, has received research funding from JayMac and Sage; has been a member of the advisory boards for Otsuka, Alkermes, and Sunovion; has been a member of the Independent Data Safety and Monitoring Committee for Janssen; and, as a Massachusetts General Hospital (MGH) employee, works with the MGH National Pregnancy Registry, which is sponsored by Teva, Alkermes, Otsuka, Actavis, and Sunovion, and works with the MGH Clinical Trials Network and Institute, which receives research funding from multiple pharmaceutical companies and the National Institute of Mental Health. No member of the CME Institute staff reported any relevant personal financial relationships.

Dr Gaughran has received honoraria for advisory work and lectures or Continuing Medical Education activity support from Roche, Bristol-Myers Squibb, Lundbeck, Otsuka, Janssen, and Sunovion; is a collaborator on a National Health Service (NHS) Innovations project co-funded by Janssen; and has a family member with professional links, including shares, to Lilly and GlaxoSmithKline. Dr Shergill is supported by a European Research Council Consolidator Award (#311686). This study represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London and a joint infrastructure grant from Guy’s and St Thomas’ Charity and the Maudsley Charity. Drs Krivoy, Joyce, Tracy, MacCabe, Lally, and Sarkar and Mr Whiskey have no personal affiliations or financial relationships with any commercial interest to disclose relative to the article.